Immunome (IMNM) Profit After Tax (2019 - 2026)
Immunome (IMNM) posted Profit After Tax of -$53.8 million for Q1 2026, up 22.98% on a QoQ basis from -$69.9 million in Q4 2025, and down 29.3% year-over-year from -$76.1 million in Q1 2025.
Immunome (IMNM) Profit After Tax (2019 - 2026) Analysis & Trends
Immunome's Profit After Tax history runs 8 years deep, the most recent figure standing at -$53.8 million for Q1 2026.
- Quarterly Profit After Tax fell 29.3% year-over-year to -$53.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$224.6 million (down 9.5% YoY) and the FY2025 annual result came in at -$212.4 million, up 27.5% from the prior year.
- Profit After Tax was -$53.8 million for Q1 2026 at Immunome, up from -$69.9 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$4.3 million in Q1 2023 and bottomed at -$129.5 million in Q1 2024.
- A 5-year average of -$41.4 million and a median of -$41.6 million in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2024 — Profit After Tax sank 2932.6% — and 2025, when it jumped 67.84%.
- Immunome's Profit After Tax stood at -$8.4 million in 2022, then tumbled by 1000.43% to -$92.6 million in 2023, then advanced by 13.37% to -$80.2 million in 2024, then advanced by 12.9% to -$69.9 million in 2025, then rose by 22.98% to -$53.8 million in 2026.
- Business Quant data shows IMNM's Profit After Tax at -$53.8 million in Q1 2026, -$69.9 million in Q4 2025, and -$57.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Immunome | 2.51 Bn | 1.93 Bn | - | -53.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.84 Mn |
| Dec 31, 2025 | -69.90 Mn |
| Sep 30, 2025 | -57.46 Mn |
| Jun 30, 2025 | -43.40 Mn |
| Mar 31, 2025 | -41.64 Mn |
| Dec 31, 2024 | -80.25 Mn |
| Sep 30, 2024 | -47.10 Mn |
| Jun 30, 2024 | -36.12 Mn |
| Mar 31, 2024 | -129.49 Mn |
| Dec 31, 2023 | -92.63 Mn |
| Sep 30, 2023 | -4.35 Mn |
| Jun 30, 2023 | -5.56 Mn |
| Mar 31, 2023 | -4.27 Mn |
| Dec 31, 2022 | -8.42 Mn |
| Sep 30, 2022 | -8.53 Mn |
| Jun 30, 2022 | -8.92 Mn |
| Mar 31, 2022 | -11.65 Mn |
| Dec 31, 2021 | -7.84 Mn |
| Sep 30, 2021 | -7.72 Mn |
| Jun 30, 2021 | -5.24 Mn |